TickerFacts.

Elanco Animal Health Inc (ELAN): Long-Term Debt

Annual figures by period end, from SEC filings.

$3.76B
As of 2025-12-31
$3.66B
As of 2026-06-30
-13.6%
3-year compound annual growth
-9.3%
5-year compound annual growth
$6.32B2018-12-31: $2.47B2019-12-31: $2.35B2020-12-31: $6.13B2021-12-31: $6.32B2022-12-31: $5.84B2023-12-31: $5.77B2024-12-31: $4.32B2025-12-31: $3.76B$3.76B
2018-12-31 Long-Term Debt (USD) 2025-12-31
Period endedLong-Term DebtChange YoYSource filing
2025-12-31$3.76B-12.9%2026-02-24, Balance as of period end
2024-12-31$4.32B-25.2%2026-02-24, Balance as of period end
2023-12-31$5.77B-1.1%2025-02-25, Balance as of period end
2022-12-31$5.84B-7.6%2024-02-26, Balance as of period end
2021-12-31$6.32B+3.1%2023-03-01, Balance as of period end
2020-12-31$6.13B+160.2%2022-02-28, Balance as of period end
2019-12-31$2.35B-4.7%2021-03-01, Balance as of period end
2018-12-31$2.47Bn/a2020-02-28, Balance as of period end

Long-Term Debt at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedLong-Term DebtChange YoY
Elanco Animal Health Inc (ELAN)2025-12-31$3.76B-12.9%
Jazz Pharmaceuticals plc (JAZZ)2025-12-31$5.36B-12.3%
BeOne Medicines Ltd. (ONC)2025-12-31$836.37Mn/a
Organon & Co. (OGN)2025-12-31$8.64B-2.7%
Amneal Pharmaceuticals, Inc. (AMRX)2025-12-31$2.57B+7.8%
Royalty Pharma plc (RPRX)2025-12-31$8.95B+17.6%
Sarepta Therapeutics, Inc. (SRPT)2025-12-31$828.97Mn/a
Bausch Health Companies Inc. (BHC)2025-12-31$20.82B-3.7%
Prestige Consumer Healthcare Inc. (PBH)2026-03-31$993.95M+0.2%

Compare ELAN, JAZZ, ONC, OGN side by side · Screen every company in Pharmaceutical Preparations ↗